PATTERN OF GYNAECOLOGICAL MALIGNANCIES IN DELTA STATE UNIVERSITY TEACHING HOSPITAL,OGHARA:A 2 YEAR REVIEW. MOFON C EBEIGBE P.E ABEDI H.O DELSUTH.

Slides:



Advertisements
Similar presentations
CHRONIC KIDNEY DISEASE THE ROLE OF GOVERNMENT IN THE MANAGEMENT. Odonmeta B. Ayo.
Advertisements

Cervical Cancer and Vaccines
OPTIONAL LOGO HERE Prevalence of endometrial cancer in symptamatic women with thickened endometrium Dr Maheswari SRINIVASAN MRCOG SpR, Mrs Shagaf BAKOUR.
Cervical Cancer. Dr. Swapna Chaudhary M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
Cervical Cancer DR KHALID H. WALI SAIT (FRCSC) ASSOCIATE PROFESSOR OF GYNECOLOGICAL ONCOLOGY King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Epidemiology of Gynaecological Cancers. General Overview On global basis cervical cancer is the most common pelvic malignancy in developing countries.
Gynecologic Cancers Presented by: Michael Goodheart, MD Assistant Professor Gynecologic Oncology The University of Iowa Hospitals & Clinics Understanding,
A significant increase in the incidence of endometrial cancer. This increased incidence of endometrial cancer has been widely interpreted to be a result.
ANNE MURUGI1,2 1.Amref Health Africa 2.University of Nairobi
A Comparative study of maternal mortality between Al-Abasia Tagali and Juba by Mahasin Hamed Haj Elsiddig.
Post Menopausal Bleeding
Management of Gynaecological Cancers. Gynaecological Cancers in NSW 1180 new cases in % of all new cancer diagnoses Crude incidence rate 35.3 per.
Reproductive health. Cancer Definition Cancer Definition The abnormal growth of cells without normal control of body. Types of Cancer  Malignant Cancer.
 The term post menopause is applied to women who have not experienced a menstrual bleed for a minimum of 12 months, assuming that they do still have.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Kenya Field Epidemiology and Laboratory Training Program (KFELTP)
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero,
Endometrial Carcinoma
Component 3-Terminology in Healthcare and Public Health Settings
Cancer Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
TEMPLATE DESIGN © Study on Risk Factors for Cervical Carcinoma at Central Women’s Hospital, Yangon Muyar Soe, Myat Thazin.
TEMPLATE DESIGN © EPIDEMIOLOGY AND PATHOLOGY OF GYNAECOLOGICAL CANCER AT BENAZIR BHUTTO HOSPITAL, RAWALPINDI, PAKISTAN.
POSTER TEMPLATE BY: Spontaneous rupture of a pyometra in a woman with a mixed mullerian tumour of the uterine corpus - A review.
Endometrial Cancer By Jessica Hall. Symptoms Unusual vaginal bleeding or discharge Difficult or painful urination Pain during intercourse Pain in the.
Factors associated with abnormal PAP Smears in a health center X – Costa Rica, 2009 Leandra Abarca 1, Julia Freer 1, Maricela Salas 2 1, MD, MsC, FETP,
TEMPLATE DESIGN © ONCOLOGICAL REFERRAL PATTERNS OF GYNAECOLOGICAL CANCER PATIENTS OVER 2010 – 2011 THE NEED FOR GYNAECOLOGIC.
By: Maureen Jaminal BIOL 316
‘Red Flags’ in Gynaecology
Epidemiology of HIV Related Malignancies among cases seen at the Nyangabgwe Referral Hospital Dr. KN NTUMBA, MD,MPH October 2007.
‘Let’s get it right - Referral for suspected Cancer’
Gynecological Malignancies. Gynecologic malignancies account for 15% of all cancers in women. Gynecologic malignancies account for 15% of all cancers.
Adherence to national guidelines in the syndromic management of sexually transmitted infections in Botswana’s primary health care Boonstra E 1, Lindbæk.
TEMPLATE DESIGN © Uterine sarcomas in RIPAS Hospital, Brunei; a 10 year retrospective study. Dr Alice Kurien, Dr Saw Ohnmar,
Welcome to the Presentation Incidence of Breast cancer in Bangladesh.
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
Impact of Physiological Symptoms and Complications of Colorectal Cancer on the Quality of Life of Patients at King Abdulaziz University Hospital Ssakher.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
SCREENING IN GYNECOLOGICAL CANCER Taravat Fakheri OB/GYN KUMS.
Midland Cancer Network 2012 Clinical Performance Conference.
HPV-related anogenital cancers
Collaboration with Community Partners to Provide Breast and Cervical Cancer Services to the Underserved University of Texas Health Sciences Center at Tyler.
Gynecologic Oncology New or Old subspecialty Samir Fouad Khalaf Professor OBGYN Al-Azhar University President
N R Manyere UZ, College of Health Sciences Department of Obstetrics and Gynaecology.
Screening for Ovarian Cancer
Liver surgery for metachronous hepatic metastases with uterine body and uterine cervix origin – a single center experience Nicolae Bacalbasa (1), Irina.
Statin use and risk of endometrial cancer:
Helle Kirkegaard1, Kresten R. Petersen1, Ole Mogensen2
Vicki Newport RGN BSc Midwifery BSc Advanced Nurse Primary Care
COMPARISON OF RISK OF MALIGNANCY INDICES AND ASSESSMENT OF DIFFERENT NEOPLASIAS IN THE ADNEXA (ADNEX) MODEL AS PREOPERATIVE MALİGNANCY EVALUATION METHODS.
Breast Cancer Research in Pakistan
Facilitator: pawin puapornpong
Keerti Singh, C Greaves, L Mohammed, A Kumar.
Male and Female Reproductive Health Concerns
Emergency Presentations in Gynaecological Oncology
Uncommon becoming common…. Case series of fallopian cancers
Gynae Oncology Trials Update
Introduction to HPV Infection & Cervical Cancer Disease GardasilTM
Introduction to HPV Infection & Cervical Cancer Disease CervarixTM
Prepared by staff in Prevention and Cancer Control.
Introduction to HPV Infection & Cervical Cancer Disease GardasilTM
Introduction to HPV Infection & Cervical Cancer Disease CervarixTM
Introduction to HPV Infection & Cervical Cancer Disease CervarixTM
Adult granulosa cell tumor and associated cancers Anna Lund Rasmussen, Finn Lauszus, Anne Hammer PhD Department of Gynecology & Obstetrics Herning Hospital.
In focus – Emerging issues in cancer control
Prepared by staff in Prevention and Cancer Control.
ENDOMETRIAL CARCINOMA
Epidemiology of cervical cancer in India: Where do we stand today
Suspected Gynaecological Cancer Recognition & Referral
Presentation transcript:

PATTERN OF GYNAECOLOGICAL MALIGNANCIES IN DELTA STATE UNIVERSITY TEACHING HOSPITAL,OGHARA:A 2 YEAR REVIEW. MOFON C EBEIGBE P.E ABEDI H.O DELSUTH.

OUTLINE INTRODUCTION OBJECTIVE MATERIALS AND METHOD RESULTS CONCLUSION RECOMMENDATION REFERENCES

INTRODUCTION Malignancies of the female genital tract are a major public health issue globally and contributes significantly to cancer related morbidity and mortality worldwide. The burden of gynaecological cancers in developing countries appears huge.1 In these countries, gynaecological cancers account for 25% of all new cancers diagnosed among women aged up to 65 years compared to 16% in the developed world.1

The pattern and prevalence of genital tract malignancies show wide geographic variations with several studies reporting varying patterns of prevalence and presentation between developing and developed countries.2,3 Within the same country, there are also differences in prevalence and pattern between urban and rural areas.2,3 Determination of pattern of gynaecological malignancies will help in setting priorities for disease prevention and control.

OBJECTIVE To determine the incidence and clinical pattern of presentation of gynaecological malignancies in DELSUTH, Oghara.

MATERIALS AND METHODS This was a descriptive study of all gynaecological malignancies whether diagnosed clinically, radiologically or surgically but confirmed by histopathology at DELSUTH from November 1 2010 to October 30, 2012. Ethical approval was obtained from the Hospital Health and Research ethical committee. Data was analyzed using SPSS 19 and results was displayed on tables and compared with available reports of similar studies from other centers.

RESULTS During the period, there were 109 patients with gynaecological malignancies which accounted for 3% of 3774 patients seen at gynaecology clinics and 21% of 494 patients admitted to the gynaecology wards. Cervical cancer was the most common gynaecological malignancy accounting for 70.30%. 13.86% had ovarian cancer, 12.87% had endometrial cancer and 2.97% had vulvar cancer respectively. There were no cases of vagina or fallopian tube cancers

The age range of the patients that had gynaecological malignancies was between 29 – 84 years with a mean age for all gynaecological malignancies of 52.37 ± 13.1years. The mean parity for patients with gynaecological cancer was Para 6. 63% of patients with cervical cancer were Para 5 and above. 46% of patients with ovarian cancer were nulliparous and this constituted the majority.

The most common presenting complaint in patients with cervical cancer was post coital bleeding and offensive vaginal discharge. 57.1% of patients with ovarian cancer presented with abdominal swelling and abdominal pain making it the commonest presenting complaint. 76.9% patients with endometrial cancer presented with Post-menopausal bleeding, abnormal vaginal discharge and abdominal pain as their main presenting complain respectively. All the patients with vulva cancer presented with vulva ulceration.

Most of the patients with cervical cancer presented with advanced disease.60.6% and 19.7% presented with stage III and IV and disease. 50% of patients with ovarian cancer presented with stage IV ovarian cancer. 46.2% patients with endometrial cancer presented with at Stage II and III of the disease. 75% of patients with vulva cancer presented with stage II disease.

CONCLUSION Cervical cancer is the most common gynaecological cancer seen in DELSUTH with most patients presenting with advanced disease. Reduction of morbidity and mortality from gynaecological cancer first involves tackling cervical cancer

RECOMMENDATIONS Education of the public especially females on the risk factors and early symptoms of cervical cancer. Establishment of dedicated and workable National cervical cancer screening programs. Strengthening of gynaecologic oncology services by better training of manpower and provision of facilities for treatment.

References 1. Iyoke C, Ugwu G. Burden of Gynaecological cancers in developing countries. World Journal of Obstetrics and Gynaecology. 2013;2(1): 1- 7. 2. Jamal S, Mamoon N, Mushtaq S, Luqman M, Moghal S. The pattern of gynaecological emergencies in 968 cases from Pakistan. Ann Saudi Med 2006; 26 (5): 382-384 3.Dey S, Hablas A, Seifeldin I, Soliman A. Urban – rural differences of gynaecological malignancies in Egypt (1999-2002).Br J Obstet Gynaecol; 117 (3):348-355.

THANK YOU.